HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Policy

US taps small San Diego biotech for experimental Ebola treatment as epidemic worsens

As an outbreak of Ebola in central Africa continues to worsen, the federal government has tapped a little-known biotech in San Diego to provide doses of an experimental antibody that may be used to treat the deadly virus.

By FierceBiotech · May 25, 2026 · via FierceBiotech
US taps small San Diego biotech for experimental Ebola treatment as epidemic worsens

Image: FierceBiotech

This is an aggregated industry headline. Read the full story at FierceBiotech →

Tags
policyformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Lilly Targets Church-Linked Pharmacies in $200M Trulicity Rebate Fraud Allegation
PolicyBriefing
Lilly Targets Church-Linked Pharmacies in $200M Trulicity Rebate Fraud Allegation
Eli Lilly’s lawsuit claims church-affiliated pharmacies and wholesalers defrauded it through fake rebate claim…
May 25, 2026
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
PolicySTAT News ↗
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable sh…
May 22, 2026
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
PolicyKFF Health News ↗
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
This fact sheet explores the history, funding, and future outlook of the President’s Emergency Plan for AIDS R…
May 22, 2026